Litcius/Paper detail

Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis

Zhigang Yuan, Daniel C. Fernandez, Jasreman Dhillon, Julieta Abraham-Miranda, Shivanshu Awasthi, Young‐Chul Kim, Jingsong Zhang, Rohit Jain, Amparo Serna, Julio M. Pow‐Sang, Michael Poch, Roger Li, Brandon J. Manley, Angelina Fink, A.O. Naghavi, Javier F. Torres–Roca, G. Daniel Grass, Sungjune Kim, Kujtim Latifi, Dylan Hunt, Peter A.S. Johnstone, Kosj Yamoah

2020Prostate Cancer and Prostatic Diseases43 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabProstate cancerBrachytherapyUrologyRadiation therapyInternal medicineOncologySurgeryCancerImmunotherapyProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysis | Litcius